Learning to think with the end in mind will help clients and their selected CRO to design and conduct the right studies.
Michael V. Templin, PhD, DABT
Advertisement
Michael V. Templin, PhD, DABT is senior scientific director, Scientific Advisory Services at Charles River.
Articles by Michael V. Templin, PhD, DABT
Advertisement
Latest Updated Articles
Outsourcing of Nonclinical Studies for Drug Development: Tips and TrendsPublished: October 1st 2019 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization
2
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
3
Why Radiopharmaceuticals Are Ideal for Treating Cancer
4
AstraZeneca Lupus Treatment Support in EU Opens Door for Self-Administration Options
5
